| 1 | endpoints | 6,735 |
| 2 | end-points | 689 |
| 3 | hyperparathyroidism | 426 |
| 4 | traumatization | 19 |
| 5 | aborters | 16 |
| 6 | patencies | 9 |
| 7 | outcome-measures | 5 |
| 8 | hlh/sepsis/mods/mas | 4 |
| 9 | outcome/s | 3 |
| 10 | oves | 3 |
| 11 | aminoacidopathies | 2 |
| 12 | beadsets | 2 |
| 13 | chancres | 2 |
| 14 | microcylinders | 2 |
| 15 | outpouchings | 2 |
| 16 | -examinations | 1 |
| 17 | 305/embrace | 1 |
| 18 | 70/k | 1 |
| 19 | aminoacido-pathies | 1 |
| 20 | amniotits | 1 |
| 21 | asthma-criteria | 1 |
| 22 | care.patients | 1 |
| 23 | chorion-amnionitis | 1 |
| 24 | co-criteria | 1 |
| 25 | comparisons.we | 1 |
| 26 | denv2/3 | 1 |
| 27 | endpoints.based | 1 |
| 28 | enpoints | 1 |
| 29 | hairloss | 1 |
| 30 | huc/d | 1 |
| 31 | hus/thrombotic | 1 |
| 32 | hypocarnitinemia | 1 |
| 33 | iga-glomerulonephritis | 1 |
| 34 | intervention.overall | 1 |
| 35 | neoplasy | 1 |
| 36 | objective.24 | 1 |
| 37 | objectives1 | 1 |
| 38 | ofcbt | 1 |
| 39 | ofolanzapine | 1 |
| 40 | ofprobiotics | 1 |
| 41 | ofreamberin | 1 |
| 42 | oh-groups | 1 |
| 43 | outcomes-clinical | 1 |
| 44 | outcomes-improvement | 1 |
| 45 | outcomes-undertreatment | 1 |
| 46 | outcomes.conclusions | 1 |
| 47 | pin-site-parameters | 1 |
| 48 | protocal | 1 |
| 49 | reconditioned | 1 |
| 50 | response.we | 1 |
| 51 | resurfacings | 1 |
| 52 | rhytidectomies | 1 |
| 53 | s-3',4'-anhydroadenosyl-l-methionine | 1 |
| 54 | seizures-aess | 1 |
| 55 | sharia | 1 |
| 56 | trial-extensions | 1 |
| 57 | v17 | 1 |
| 58 | yttrium-aluminum-monoclinic | 1 |
| 1 | -examinations | 1 |
| 2 | 305/embrace | 1 |
| 3 | 70/k | 1 |
| 4 | aborters | 16 |
| 5 | aminoacido-pathies | 1 |
| 6 | aminoacidopathies | 2 |
| 7 | amniotits | 1 |
| 8 | asthma-criteria | 1 |
| 9 | beadsets | 2 |
| 10 | care.patients | 1 |
| 11 | chancres | 2 |
| 12 | chorion-amnionitis | 1 |
| 13 | co-criteria | 1 |
| 14 | comparisons.we | 1 |
| 15 | denv2/3 | 1 |
| 16 | end-points | 689 |
| 17 | endpoints | 6,735 |
| 18 | endpoints.based | 1 |
| 19 | enpoints | 1 |
| 20 | hairloss | 1 |
| 21 | hlh/sepsis/mods/mas | 4 |
| 22 | huc/d | 1 |
| 23 | hus/thrombotic | 1 |
| 24 | hyperparathyroidism | 426 |
| 25 | hypocarnitinemia | 1 |
| 26 | iga-glomerulonephritis | 1 |
| 27 | intervention.overall | 1 |
| 28 | microcylinders | 2 |
| 29 | neoplasy | 1 |
| 30 | objective.24 | 1 |
| 31 | objectives1 | 1 |
| 32 | ofcbt | 1 |
| 33 | ofolanzapine | 1 |
| 34 | ofprobiotics | 1 |
| 35 | ofreamberin | 1 |
| 36 | oh-groups | 1 |
| 37 | outcome-measures | 5 |
| 38 | outcome/s | 3 |
| 39 | outcomes-clinical | 1 |
| 40 | outcomes-improvement | 1 |
| 41 | outcomes-undertreatment | 1 |
| 42 | outcomes.conclusions | 1 |
| 43 | outpouchings | 2 |
| 44 | oves | 3 |
| 45 | patencies | 9 |
| 46 | pin-site-parameters | 1 |
| 47 | protocal | 1 |
| 48 | reconditioned | 1 |
| 49 | response.we | 1 |
| 50 | resurfacings | 1 |
| 51 | rhytidectomies | 1 |
| 52 | s-3',4'-anhydroadenosyl-l-methionine | 1 |
| 53 | seizures-aess | 1 |
| 54 | sharia | 1 |
| 55 | traumatization | 19 |
| 56 | trial-extensions | 1 |
| 57 | v17 | 1 |
| 58 | yttrium-aluminum-monoclinic | 1 |
| 1 | objectives1 | 1 |
| 2 | denv2/3 | 1 |
| 3 | objective.24 | 1 |
| 4 | v17 | 1 |
| 5 | hypocarnitinemia | 1 |
| 6 | sharia | 1 |
| 7 | asthma-criteria | 1 |
| 8 | co-criteria | 1 |
| 9 | yttrium-aluminum-monoclinic | 1 |
| 10 | hus/thrombotic | 1 |
| 11 | huc/d | 1 |
| 12 | reconditioned | 1 |
| 13 | endpoints.based | 1 |
| 14 | 305/embrace | 1 |
| 15 | s-3',4'-anhydroadenosyl-l-methionine | 1 |
| 16 | ofolanzapine | 1 |
| 17 | response.we | 1 |
| 18 | comparisons.we | 1 |
| 19 | 70/k | 1 |
| 20 | outcomes-clinical | 1 |
| 21 | protocal | 1 |
| 22 | intervention.overall | 1 |
| 23 | hyperparathyroidism | 426 |
| 24 | ofreamberin | 1 |
| 25 | traumatization | 19 |
| 26 | outcome/s | 3 |
| 27 | hlh/sepsis/mods/mas | 4 |
| 28 | ofprobiotics | 1 |
| 29 | patencies | 9 |
| 30 | aminoacido-pathies | 1 |
| 31 | aminoacidopathies | 2 |
| 32 | rhytidectomies | 1 |
| 33 | chancres | 2 |
| 34 | outcome-measures | 5 |
| 35 | oves | 3 |
| 36 | resurfacings | 1 |
| 37 | outpouchings | 2 |
| 38 | chorion-amnionitis | 1 |
| 39 | iga-glomerulonephritis | 1 |
| 40 | trial-extensions | 1 |
| 41 | outcomes.conclusions | 1 |
| 42 | -examinations | 1 |
| 43 | oh-groups | 1 |
| 44 | microcylinders | 2 |
| 45 | pin-site-parameters | 1 |
| 46 | aborters | 16 |
| 47 | seizures-aess | 1 |
| 48 | hairloss | 1 |
| 49 | beadsets | 2 |
| 50 | amniotits | 1 |
| 51 | care.patients | 1 |
| 52 | end-points | 689 |
| 53 | endpoints | 6,735 |
| 54 | enpoints | 1 |
| 55 | ofcbt | 1 |
| 56 | outcomes-improvement | 1 |
| 57 | outcomes-undertreatment | 1 |
| 58 | neoplasy | 1 |